[ Price : $8.95]
An FDA inspection of Philips Respironics results in a 29-page Form FDA-483 based on a Class 1 recall follow-up involving its conti...[ Price : $8.95]
The Biden Administration chooses former FDA head Robert Califf as its FDA commissioner nominee.[ Price : $8.95]
Apellis Pharmaceuticals says it will file an NDA during the first half of 2022 for intravitreal pegcetacoplan for treating a blind...[ Price : $8.95]
A Journal of Clinical Pharmacology study finds that FDA has less oversight of overseas clinical trials that are used to form the b...[ Price : $8.95]
FDA approves a PharmaEssentia BLA for Besremi injection to treat adults with polycythemia vera, a blood disease associated with re...[ Price : $8.95]
The Oklahoma Supreme Court says a lower court erred in determining that J&J violated the states public nuisance law in the way it ...[ Price : $8.95]
FDA grants Elevar Therapeutics an orphan drug designation for rivoceranib and its use for treating hepatocellular carcinoma.[ Price : $8.95]
FDA accepts for priority review a Boehringer Ingelheim and Eli Lilly supplemental NDA for Jardiance (empagliflozin) 10 mg for redu...